Roche v ANSM: the French Avastin stand-off
This article was originally published in Scrip
Executive Summary
It's a war of words: Roche and the French regulator ANSM have locked horns over plans to make Avastin available off-label for wet AMD, and it's not easy to say who will emerge the winner.